BOF Cote

Product Description

BOF Cote was a refractory coating product manufactured by Narco (National Refractories and Minerals Corporation) and produced during the period spanning 1966 through 1975. The product was designed specifically for use in basic oxygen furnace (BOF) steelmaking operations, one of the most demanding industrial environments in heavy manufacturing. Basic oxygen furnaces operate at extraordinarily high temperatures to convert molten pig iron into steel, and the refractory materials lining and protecting those furnaces were required to withstand continuous thermal stress, chemical exposure, and mechanical wear.

Refractory coatings such as BOF Cote served a protective and restorative function within these industrial systems. Applied to the interior surfaces of furnaces, ladles, and related steelmaking equipment, these coatings helped maintain structural integrity, extend the service life of refractory linings, and protect underlying materials from the intense heat and corrosive slag produced during the steelmaking process. The product was positioned as a specialized industrial solution during an era when the basic oxygen furnace process was rapidly expanding across the American steel industry, replacing older open-hearth methods and driving demand for compatible high-performance refractory materials.

Narco was a recognized name in the industrial refractory sector during the mid-twentieth century, supplying materials to steel mills, foundries, and other high-temperature processing facilities throughout the United States. BOF Cote represented one product within a broader line of refractory solutions the company offered to heavy industrial customers.

Asbestos Content

BOF Cote contained chrysotile asbestos as a component of its formulation. Chrysotile, sometimes referred to as white asbestos, is a fibrous silicate mineral that was widely incorporated into refractory and high-temperature industrial products during the mid-twentieth century because of its heat resistance, binding properties, and relative availability. It belongs to the serpentine mineral group and was the most commercially prevalent form of asbestos used in industrial manufacturing in the United States during the decades BOF Cote was produced.

The inclusion of chrysotile in refractory coatings was consistent with widespread industry practice during the 1966–1975 production window. Asbestos fibers contributed structural reinforcement to coating materials and helped those materials perform under the thermal cycling and extreme temperatures characteristic of steelmaking operations. Despite these functional properties, chrysotile asbestos is classified as a known human carcinogen by regulatory and scientific authorities including the International Agency for Research on Cancer (IARC), the Environmental Protection Agency (EPA), and the Occupational Safety and Health Administration (OSHA). No level of occupational asbestos exposure has been established as safe under current regulatory guidance.

How Workers Were Exposed

Industrial workers employed in steelmaking facilities and related heavy industrial environments represent the primary population with documented exposure potential to BOF Cote. The nature of refractory coating work and the conditions in which BOF Cote was applied created multiple pathways through which airborne asbestos fibers could be released and inhaled.

Application of refractory coatings in furnace environments typically involved mixing, spraying, troweling, or otherwise working with materials in close proximity. When products containing chrysotile asbestos were handled, mixed, or disturbed during application, the mechanical action involved could release asbestos fibers into the surrounding air. Workers performing these tasks in confined or poorly ventilated industrial spaces faced the risk of inhaling respirable fibers at concentrations that may have exceeded safe exposure thresholds.

Maintenance and repair activities presented additional exposure risks. Refractory linings and coatings within basic oxygen furnaces required periodic inspection, repair, and relining as they degraded from thermal and chemical stress. Workers involved in breaking out, chipping, or removing old refractory material containing asbestos—or working in proximity to others doing so—could disturb previously stable asbestos-containing material and generate significant fiber release. Steelmakers, furnace operators, maintenance crews, and laborers working in and around BOF operations during the years the product was in use all potentially encountered these conditions.

The industrial environments where BOF Cote was used were often characterized by high heat, physical labor, and variable ventilation conditions that could concentrate airborne contaminants. Personal protective equipment and respiratory protection practices during the 1966–1975 era were frequently inadequate by modern standards, and worker awareness of asbestos hazards was often limited due to the industry’s historical pattern of withholding or downplaying information about the health risks associated with asbestos-containing products.

Diseases associated with occupational chrysotile asbestos exposure include mesothelioma, lung cancer, asbestosis, and other serious pulmonary conditions. These diseases typically have long latency periods—often spanning 20 to 50 years between initial exposure and clinical diagnosis—meaning that individuals exposed to BOF Cote during its production era may be receiving diagnoses today.

BOF Cote does not have an associated asbestos bankruptcy trust fund. No dedicated trust has been established to compensate individuals harmed by this specific product through the trust fund system that was created as part of asbestos-related corporate bankruptcy proceedings under Chapter 11 of the U.S. Bankruptcy Code.

Compensation for individuals diagnosed with asbestos-related diseases following exposure to BOF Cote has been pursued through civil litigation in the tort system. Litigation records document claims brought against Narco and related parties by individuals alleging that exposure to asbestos-containing refractory products, including materials used in steelmaking operations, caused serious and fatal diseases. Plaintiffs alleged that manufacturers of asbestos-containing refractory products knew or should have known of the hazards associated with asbestos exposure and failed to provide adequate warnings to workers who used or worked near their products.

Plaintiffs alleged that this failure to warn deprived workers of the opportunity to take protective measures that might have reduced or prevented their asbestos exposure. Litigation records document claims spanning mesothelioma, lung cancer, and asbestosis diagnoses among industrial workers with histories of employment in steel mills and related facilities where asbestos-containing refractory products were in use.

Individuals diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related conditions who have a documented history of working with or around BOF Cote or similar refractory coatings during the 1966–1975 production period should consult with an attorney experienced in asbestos litigation. Legal counsel can evaluate the specific facts of an individual’s work history, exposure circumstances, and medical diagnosis to identify all potential avenues for compensation, which may include civil litigation against surviving manufacturers, related corporate entities, or other responsible parties in the product supply chain.

The long latency period of asbestos-related diseases means that statutes of limitations in asbestos cases are typically measured from the date of diagnosis rather than the date of exposure. Individuals and families affected by these diseases are encouraged to seek legal advice promptly following diagnosis to preserve all available legal options.